PPBT (Purple Biotech) Earnings per share growth rate in current year
Purple Biotech possesses significant market influence due to the uniqueness of the CM24 antibody. The annual earnings per share growth vector confirms this potential, with the 88.80 metric serving as the target level. Purple Biotech focuses on targeted therapy for resistant forms of cancer. Currently, the business is independently developing clinical trials while utilizing only contract manufacturing sites.
Analytical breakdowns and data insights for company Purple Biotech (PPBT)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
All Debt to Shareholders' Equity Ratio Purple Biotech|PPBT - Long-Term Debt to Equity|Current Liabilities to Equity purple-biotech.com|PPBT - Company Debts|Debt to Book Capitalization Ratio Kitov Pharma|PPBT - Company Long-Term Debts|Short-Term Debt Purple Biotech|Intermediate Coverage Ratio purple-biotech.com
- financial results and valuation multiples details:
PPBT - Net Profit|Expected Profit Purple Biotech|PPBT - P/E Multiple|Market Cap to Projected Earnings Kitov Pharma|PPBT - Price/Earnings to Growth Ratio|Company Value to EBITDA Kitov Pharma|PPBT - Operating profit before deduction of amortization|Earnings per share for the last four quarters Purple Biotech|PPBT - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months purple-biotech.com|PPBT - Earnings growth in current year|Expected earnings per share growth for next year Purple Biotech
Basic company analysis:Purple Biotech Ltd, PPBT
Investors frequently weigh the speculative interest in Purple Biotech (PPBT) against its actual profit generation efficiency. The annual earnings per share trajectory calculates the percentage shift in EPS relative to the previous year, demonstrating the dynamics of capital return per share. For this Israeli business, this trend reflects the ability to maintain operational resilience and scale profitability despite regional geopolitical instability.
Direct competitors
BeiGene Ltd. - Earnings per share increase in current year|HALO (Halozyme Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Revolution Medicines Corp RVMD|Earnings per share growth in current year Ascentage Pharma Group (AAPG)|CGON: Earnings per share trend in current year|UroGen Pharma - Net earnings per share growth this year|Earnings growth in current year Bicara Therapeutics Inc BCAX|PSNL - Earnings per share growth in current year|Earnings per share increase in current year ERAS (Erasca Oncology)|Delcath Systems, Inc. (DCTH) - Earnings per share growth in current year|Earnings per share trend in current year YMAB (ymabs.com)|Earnings per share growth in current year Aura Biosciences|Earnings per share growth in current year CADL|Earnings growth in current year ARAY|SLS - Earnings per share growth rate in current year|Actuate Therapeutics, Inc. - Net earnings per share growth this year|Earnings per share increase in current year CTOR|TuHURA - Earnings growth in current year|TARA: Earnings per share growth in current year|FATE: Earnings growth in current year|WHWK - Expected net earnings per share growth this year|Earnings per share growth in current year TScan Therapeutics Inc|Earnings per share growth rate in current year Champions Oncology Corp CSBR|Net earnings per share growth this year XBIT (XBiotech Inc.)|Net earnings per one share growth for the current year CVM|Earnings growth in current year OSTX (OS Therapies Inc)|radiopharmtheranostics.com (RADX) - Earnings per share growth rate in current year|Artiva - Earnings growth in current year|Adlai Nortye Ltd. (ANL) - Net earnings per share growth this year|VERU: Earnings growth in current year|Tempest Therapeutics Inc - Earnings per share increase in current year|Earnings per share growth in current year Xilio Therapeutics Inc|Enochian BioSciences - Earnings per share trend in current year|Earnings per share growth in current year Mural Oncology plc (MURA)|KAPA: Earnings per share trend in current year|Earnings growth in current year OKUR (OnKure Therapeutics)|CytoMed Therapeutics Ltd - Earnings per share growth in current year|CRIS: Net earnings per share growth this year|Apollomics, Inc. - Net earnings per one share growth for the current year|THAR: Earnings growth in current year|Net earnings per share growth this year Advanced Biomed|GNPX (Genprex) - Earnings growth in current year|Earnings growth in current year Calidi Bio|Earnings per share growth in current year Sunshine Biopharma, Inc. (SBFM)|xeneticbio.com - Earnings per share growth this year|Earnings growth in current year SLRX (Salarius Pharmaceuticals)|AONC - Net earnings per share growth this year|BeiGene - Earnings growth in current year|Earnings per share growth rate in current year Checkpoint Therapeutics Inc.|Elevation Oncology (ELEV) - Earnings per share growth in current year|iCAD - Earnings per share increase in current year|Net earnings per share growth this year IKNA|NTBL: Earnings per share increase in current year|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Inc MOR|NAYA Bio - Net earnings per share growth this year|Earnings growth in current year Ascentage AAPGV
